Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening

Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening Letter (989) Total Article Views Authors: Nance KV Published Date January 2013 Volume 2013:5 Pages 1 - 3 DOI: http://dx.doi.org/10.2147/DHPS.S41886 Received: 20 December 2012 Accepted: 20 December 2012 Published: 21 January 2013 Keith V Nance Medical Directory of Cytology, Rex Hospital, Raleigh, and Department of Pathology, The University of North Carolina School of Medicine, Chapel Hill, NC, USA I read with interest the recently published article by Naryshkin and Austin entitled "Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening".1 The article is a single case report of squamous cell carcinoma of the cervix diagnosed in a patient who had negative Hybrid Capture 2 (Qiagen NV, Hilden, Germany) high-risk human papillomavirus testing from SurePath (Becton-Dickinson, Franklin Lakes, NJ) samples. The authors then discuss several valid points regarding the use of human papillomavirus testing and cervical cancer screening not approved by the US Food and Drug Administration (FDA). Their conclusion is that such testing should not be done using the SurePath collection medium. View the original paper by Naryshkin and Austin. Post to: Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter Readers of this article also read: Optical imaging to trace near infrared fluorescent zinc oxide nanoparticles following oral exposure Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening Pseudomembranous colitis within radiotherapy field following concurrent chemoradiation therapy: a case report Collagen-based wound dressings for the treatment of diabetes-related foot ulcers: a systematic review Repeated renal infarction in native and transplanted kidneys due to left ventricular thrombus formation caused by antiphospholipid antibody syndrome Validation of an equation for estimating maximal oxygen consumption of nonexpert adult swimmers Characterization and stability studies of a novel liposomal cyclosporin A prepared using the supercritical fluid method: comparison with the modified conventional Bangham method